Screener
Fulgent Genetics, Inc. FLGT Acquisitions
Acquisitions at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from sale of fixed assets | 8 | 2 |
| Purchase of marketable securities | (10,011) | — |
| Purchases of fixed assets | (5,202) | (4,718) |
| Acquisition of businesses, net of cash | (55,567) | — |
| Net cash provided by investing activities | 10,939 | 27,729 |
| Cash flow from financing activities: | ||
| Repurchase of common stock | (40,078) | (8,679) |
| Common stock withholding for employee tax obligations | (4,200) | (1,887) |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s acquisitions?
- Fulgent Genetics, Inc. (FLGT) reported acquisitions of $55.57M in Q1 2026.
- What does acquisitions mean?
- Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.
Ask your AI about Fulgent Genetics, Inc.'s acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude